
New Drug for Prostate Cancer: Ipatasertib, an AKT Inhibitor
- Wellness
- Admin COUPONS
- September 24, 2020
When used in combination with abiraterone, the new drug showed activity in metastatic castration-resistant prostate cancer in the IPATential 150 trial. Medscape Medical News
%%item_READ_MORE…_button%%